FDA Accepts Application for Botox to Treat Masseter Muscle Prominence
If approved, the neurotoxin would be the first indicated for the temporary improvement of marked to very marked masseter muscle prominence in the United States.
If approved, the neurotoxin would be the first indicated for the temporary improvement of marked to very marked masseter muscle prominence in the United States.
